Pages that link to "Q34381064"
Jump to navigation
Jump to search
The following pages link to Low incidence of BRCA2 mutations in breast carcinoma and other cancers (Q34381064):
Displaying 50 items.
- Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells (Q22003975) (← links)
- Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals (Q22010135) (← links)
- Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas (Q22010496) (← links)
- Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains (Q24645684) (← links)
- The BRCA2 gene product functionally interacts with p53 and RAD51 (Q24650406) (← links)
- Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish (Q27342643) (← links)
- PALB2: the hub of a network of tumor suppressors involved in DNA damage responses (Q28243398) (← links)
- A canine model of familial mammary gland neoplasia (Q28271567) (← links)
- RETRACTED: The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer (Q28302841) (← links)
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers (Q28306997) (← links)
- Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation (Q28586360) (← links)
- Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. (Q31926021) (← links)
- A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing. (Q33214483) (← links)
- The genetic basis of breast cancer and its clinical implications (Q33536033) (← links)
- BRCA1 and BRCA2 in breast cancer (Q33658723) (← links)
- A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland (Q33680801) (← links)
- Overexpression of BRCA2 gene in sporadic breast tumours. (Q33875158) (← links)
- Functional domains of the BRCA1 and BRCA2 proteins (Q33923811) (← links)
- Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens (Q34135331) (← links)
- Genetically engineered rodent models of mammary gland carcinogenesis: an overview (Q34160186) (← links)
- Treatment options for patients with triple-negative breast cancer (Q34331406) (← links)
- Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene (Q34419177) (← links)
- On the birth of breast cancer (Q34487109) (← links)
- Hypermutability in carcinogenesis (Q34603856) (← links)
- Molecular alterations in sporadic breast cancer (Q34987420) (← links)
- Screening women at increased risk with MRI (Q35173107) (← links)
- Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. (Q35238410) (← links)
- A low proportion of BRCA2 mutations in Finnish breast cancer families. (Q35238446) (← links)
- Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer (Q35238455) (← links)
- A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing (Q35336961) (← links)
- BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer (Q35674192) (← links)
- BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications (Q35810230) (← links)
- Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context (Q36146953) (← links)
- Tumor suppressor genetics (Q36252762) (← links)
- Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers (Q36431320) (← links)
- Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma (Q36431503) (← links)
- Germline BRCA2 mutations in men with breast cancer (Q36431527) (← links)
- Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. (Q36619794) (← links)
- Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis (Q36623649) (← links)
- Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas (Q36645975) (← links)
- Direct isolation of human BRCA2 gene by transformation-associated recombination in yeast (Q36656191) (← links)
- Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis (Q36973287) (← links)
- Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter (Q37021548) (← links)
- Mammary cancer susceptibility: human genes and rodent models (Q37024868) (← links)
- Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer (Q38457061) (← links)
- Down regulation of BRCA2 causes radio-sensitization of human tumor cells in vitro and in vivo (Q39996913) (← links)
- Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines. (Q40749668) (← links)
- Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells (Q41025250) (← links)
- Recent advances in understanding of genetic susceptibility to breast cancer (Q41170356) (← links)
- Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance (Q41487999) (← links)